<SEC-DOCUMENT>0000950103-23-011244.txt : 20230912
<SEC-HEADER>0000950103-23-011244.hdr.sgml : 20230912
<ACCEPTANCE-DATETIME>20230801122230
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0000950103-23-011244
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230801

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			111, Inc.
		CENTRAL INDEX KEY:			0001738906
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		3-4/F, NO.295 ZUCHONGZHI ROAD
		STREET 2:		PUDONG NEW AREA
		CITY:			SHANGHAI
		STATE:			F4
		ZIP:			201203
		BUSINESS PHONE:		862120536666

	MAIL ADDRESS:	
		STREET 1:		3-4/F, NO.295 ZUCHONGZHI ROAD
		STREET 2:		PUDONG NEW AREA
		CITY:			SHANGHAI
		STATE:			F4
		ZIP:			201203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	New Peak Group
		DATE OF NAME CHANGE:	20180427
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><IMG SRC="image_001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">August 1, 2023</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Division of Corporation Finance<BR>
U.S. Securities &amp; Exchange Commission<BR>
100 F Street, NE<BR>
Washington, D.C. 20549</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Re:</FONT></TD>
    <TD STYLE="width: 96%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">111, Inc.<BR>
Annual Report on Form 20-F</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Response Dated September 27, 2022<BR>
File No. 001-38639</P></TD></TR>
  </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%; font-size: 10pt"><FONT STYLE="font-size: 10pt"><I>Attn:</I></FONT></TD>
    <TD STYLE="width: 94%; font-size: 10pt"><FONT STYLE="font-size: 10pt"><I>Division of Corporation Finance<BR>
Office of Trade &amp; Services</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><U>VIA EDGAR</U></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Dear Kyle Wiley and Jennifer Thompson:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">This letter sets forth the responses of 111, Inc.
(the &ldquo;<B>Company</B>&rdquo;) to the comments (the &ldquo;<B>Comments</B>&rdquo;) the Company received from the staff of the Division
of Corporation Finance (the &ldquo;<B>Staff</B>&rdquo;) of the Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;)
in a letter dated July 21, 2023.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">For the Staff&rsquo;s convenience, we have included
herein the Comments in bold, and the Company&rsquo;s responses are set forth immediately below the Comments.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><U>General Note to the Staff:</U></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Company respectfully submits in this letter its proposed amendments
to the disclosures contained in the Company&rsquo;s annual report on Form 20-F for the fiscal year ended December 31, 2022 filed with
the Commission on April 28, 2023 (the &ldquo;<B>2022 Annual Report</B>&rdquo;) (with deletions shown as strike-through and additions underlined).
The Company undertakes to include the proposed disclosures substantially as set forth below in its annual report on Form 20-F for the
fiscal year ended December 31, 2023 (the &ldquo;<B>2023 Annual Report</B>&rdquo;), to the extent such disclosures are required, subject
to the Staff&rsquo;s further review and comment with appropriate revisions and updates to reflect the Company&rsquo;s circumstances at
the time when it files the 2023 Annual Report. All capitalized terms used but not defined in this letter shall have the meaning ascribed
to such terms in the 2022 Form 20-F.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; font-size: 10pt"><FONT STYLE="font-size: 10pt"><U>Annual Report on Form 20-F for Fiscal Year Ended December 31, 2022</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><U>Item 16I. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections, page 149</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We note your statement
    that you reviewed your register of members and public filings made by your shareholders in connection with your required submission under
    paragraph (a). Please supplementally describe any additional materials that were reviewed and tell us whether you relied upon any legal
    opinions or third party certifications such as affidavits as the basis for your submission. In your response, please provide a similarly
    detailed discussion of the materials reviewed and legal opinions or third party certifications relied upon in connection with the required
    disclosures under paragraphs (b)(2) and (3).</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I><U>Response</U></I></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><U>Submission under paragraph (a) of Item 16I </U></P>
<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Company respectfully advises the Staff that it did not rely on any
legal opinions or third-party certifications, such as affidavits, as the basis for its submission under paragraph (a) of Item 16I on Exhibit
16.1 to the 2022 Annual Report (the &ldquo;<B>Exhibit 16.1</B>&rdquo;).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">As the Company has disclosed in its submission under paragraph (a) of
Item 16I in Exhibit 16.1, based on an examination of the Company&rsquo;s register of members and the public filings on Schedule 13D and
13G made by the Company&rsquo;s shareholders (the &ldquo;<B>Public Filings</B>&rdquo;), the Company believes that it had a reasonable
basis to conclude that it is not controlled by a foreign government entity. As provided in Exhibit 16.1, as of March 31, 2023, Sunny Bay
Global Limited, ClearVue Partners, L.P., Infinity Cosmo Limited and First Pharmacia International beneficially owned approximately 21.4%,
9.5%, 6.9% and 5.2% of the Company&rsquo;s total outstanding ordinary shares, respectively, and collectively beneficially owned 43.0%
of the Company&rsquo;s total outstanding ordinary shares. No other shareholder owned more than 5% of the Company&rsquo;s outstanding ordinary
shares as of March 31, 2023.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Additionally, based on publicly available information and the Company&rsquo;s
inquiries with its shareholders through questionnaires and the review of the bios:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD>Sunny Bay Global Limited, a company incorporated in the British Virgin Islands, is wholly owned by Mr. Junling Liu. Mr. Junling Liu
is a natural person not affiliated with any foreign government entities;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD><TD><FONT STYLE="font-size: 10pt">ClearVue Partners, L.P. is an exempted limited partnership organized and existing under the laws of
Cayman Islands. ClearVue Partners GP, L.P., an exempted limited partnership organized and existing under the laws of Cayman Islands, is
the general partner of ClearVue Partners, L.P. ClearVue Partners Ltd. is the general partner of ClearVue Partners GP, L.P. Mr. Harry Chi
owns 60% of the equity interests in ClearVue Partners Ltd. and may be deemed to beneficially own Class&nbsp;A Ordinary Shares represented
by ADSs directly held by ClearVue Partners, L.P. and Class&nbsp;A Ordinary Shares represented by ADSs directly held by ClearVue YW Holdings,&nbsp;Ltd.
</FONT>Mr. <FONT STYLE="font-size: 10pt">Harry Chi is a natural person not affiliated with any foreign government entities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD>Infinity Cosmo Limited, a company incorporated in the British Virgin Islands, is controlled by Gang Yu Irrevocable Trust. The beneficiaries
of Gang Yu Irrevocable Trust are Mr. Gang Yu&rsquo;s family members. Mr. Gang Yu may be deemed to be the beneficial owner of the Shares
held by Infinity Cosmo Limited. Mr. Gang Yu is a natural person not affiliated with any foreign government entities;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD>First Pharmacia International, an exempted company organized and existing under the laws of Cayman Islands, is the wholly-owned subsidiary
of BVCF Realization Fund, L.P. BVCF Realization Fund GP, Ltd is the general partner of BVCF Realization Fund, L.P. Mr. Zhi Yang, is the
sole director and sole shareholder of BVCF Realization Fund GP, Ltd. Mr. Zhi Yang is a natural person not affiliated with any foreign
government entities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In addition, as of the date of the 2022 Annual Report, since each of
the Company&rsquo;s consolidated subsidiaries is owned or controlled, directly or indirectly, by the Company, the Company has relied upon
the materials as described in the foregoing paragraphs, and did not rely upon additional documentation, to reach its conclusion that none
of these subsidiaries is owned or controlled by any foreign government entities, except that approximately 2.7% of the outstanding shares
of 1 Pharmacy Technology (Shanghai) Co., Ltd. were indirectly and ultimately beneficially owned by PRC governmental entities. Please refer
to the Company&rsquo;s responses to the Staff&rsquo;s Comments No. 2.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Based on the above, the Company believes it is reasonable and sufficient
to rely on its register of members, the Public Filings, the publicly available information through desktop search, and inquiries with
certain shareholders through questionnaires and review of the Company&rsquo;s internal records as to their government ownership or support
to form the basis for the Company to draw the conclusion as disclosed in its submission under paragraph (a) of Item 16I in Exhibit 16.1.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><U>Submission under paragrah (b) of Item 16I </U>With respect to the
disclosures required under paragraph (b)(2) and (b)(3) of Item 16I, the Company has relied on the materials and information as set forth
in submission under paragraph (a) of Item 16I discussed above, including register of members, the Public Filings and inquiry with certain
shareholders as to their government ownership or support, to form the basis for the Company to draw the conclusion in its disclosure
in response to paragraph (b)(2) and (b)(3) of Item 16I.</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We note that your disclosures
pursuant to Items 16I(b)(2), (b)(3) and (b)(4) are provided for you and your &ldquo;material operating entities.&rdquo; Please note that
Item 16I(b) requires that you provide disclosures for yourself and your consolidated foreign operating entities, including variable interest
entities or similar structures, and does not contemplate limiting the disclosure.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>With respect to (b)(2), please supplementally clarify the jurisdictions in which your consolidated foreign operating entities are
organized or incorporated and provide the percentage of your shares or the shares of your consolidated operating entities owned by governmental
entities in each foreign jurisdiction in which you have consolidated operating entities in your supplemental response.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>With respect to (b)(3) and (b)(4), please provide the required information for you and all of your consolidated foreign operating
entities in your supplemental response.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I><U>Response</U></I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In response to the Staff&rsquo;s comment, the Company respectfully advises
the Staff that its consolidated operating entities are organized or incorporated in the mainland China, Hong Kong, the Cayman Islands
and the British Virgin Islands.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">With respect to (b)(2), as of the date of the 2022 Annual Report, none
of the shares of the Company or any of the Company&rsquo;s consolidated operating entities were owned by governmental entities in the
jurisdiction in which the Company or such operating entities are incorporated or otherwise organized, except that approximately 2.7% of
the outstanding shares of 1 Pharmacy Technology (Shanghai) Co., Ltd. were indirectly and ultimately beneficially owned by PRC governmental
entities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">With respect to (b)(3), no governmental entity in the mainland China
has a controlling financial interest in the Company or any of the Company&rsquo;s consolidated operating entities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif">With respect to (b)(4), please refer to the Company&rsquo;s responses
to the Staff&rsquo;s Comments No. 3.</P>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In order to clarify the
scope of your review, please supplementally describe the steps you have taken to confirm that none of the members of your board or the
boards of your consolidated foreign operating entities are officials of the Chinese Communist Party. For instance, please tell us how
the board members&rsquo; current or prior memberships on, or affiliations with, committees of the Chinese Communist Party factored into
your determination. In addition, please tell us whether you have relied upon third party certifications such as affidavits as the basis
for your disclosure.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I><U>Response</U></I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif">The Company respectfully advises the Staff that in preparation of its
required disclosures under paragraph (b)(4) of Item 16I of Form 20-F, the Company has reviewed publicly available information through
desktop search and its internal records and further conducted inquiries with, and reviewed the bios of, the members of the board of directors
of the Company and its consolidated operating entities to determine whether each of such individuals is an official of the Chinese Communist
Party. The Company has taken into consideration the Directors&rsquo; current or prior memberships on, or affiliations with, committees
of the Chinese Communist Party, to the extent such information is known to the Company, into its determination in connection with its
disclosures under paragraph (b)(4) of Item 16I. The Company did not rely upon third-party certifications such as affidavits as the basis
for disclosure and did not believe such third-party certifications were either available or necessary to its determination. After taking
the foregoing steps, nothing has come to the Company&rsquo;s attention suggesting that any such individual is an official of the Chinese
Communist Party or has any memberships or affiliations that could reasonably result in such individual being considered an official of
the Chinese Communist Party. Accordingly, the Company re-confirms that to the best of its knowledge, as of the date of the 2022 Annual
Report, none of the members of board of directors of the Company or each of the Company&rsquo;s consolidated operating entities was an
official of the Chinese Communist Party.</P>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With respect to your
disclosure pursuant to Item 16I(b)(5), we note that you have included language that such disclosure is &ldquo;to our best knowledge.&rdquo;
Please supplementally confirm without qualification, if true, that your articles and the articles of your
consolidated foreign operating entities do not contain wording from any charter of the Chinese Communist Party.</P>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I><U>Response</U></I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif">The Company respectfully submits that as of the date of the 2022 Annual
Report, the then effective memorandum and articles of association of 111, Inc. and the articles of incorporation (or equivalent organizing
document) of each of the Company&rsquo;s consolidated foreign operating entities did not contain any charter of the Chinese Communist
Party, including the text of any such charter. Please kindly note that this statement is being made without any qualification as indicated
in the Staff&rsquo;s comment.</P>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>5. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We note that your disclosure pursuant to Item 16I(b)(5) refers
to &ldquo;our company.&rdquo; It is unclear from the context of your disclosures pursuant to Item 16I(b) whether terms such as this are
meant to encompass you and all of your consolidated foreign operating entities or whether in some instances these terms refer solely to
111, Inc. Please note that Item 16I(b) requires that you provide each disclosure for yourself and your consolidated foreign operating
entities, including variable interest entities or similar structures. To clarify this matter, please provide the information required
by Item 16I(b)(5) for you and all of your consolidated foreign operating entities in your supplemental response.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I><U>Response</U></I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Company respectfully submits that those items are meant to encompass
111, Inc. and all of its consolidated foreign operating entities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.2in"><FONT STYLE="background-color: white">(iv) the currently effective
Articles of Associates <U>(or, where applicable, equivalent organizing document)</U> of <STRIKE>our company</STRIKE> <U>the Company and
all of its consolidated foreign operating entities do</U> <STRIKE>does</STRIKE> not contain any charter of the Chinese Communist Party,
including the text of any such articles.</FONT><FONT STYLE="font-size: 10pt"><I>&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.2in">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If you have further questions or comments regarding, or require further
information or clarification of, any of the responses provided in this letter or if the Commission has any questions with respect to 111,
Inc.&rsquo;s Annual Report on Form 20-F, please contact the undersigned or Kevin Zhang (Tel: +852-2533-3384) of Davis Polk &amp; Wardwell
LLP.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt; text-align: justify">Sincerely yours,</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt; text-align: justify">111, Inc.</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: justify; width: 4%">By:</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 35%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; border-bottom: black 0.75pt solid">/s/ Junling
Liu</P></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: justify">Name: Junling Liu</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: justify">Title: Chief Executive Officer</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt; text-align: justify">cc:</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Kevin Zhang</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Davis Polk &amp; Wardwell LLP</TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !/ +X# 2(  A$! Q$!_\0
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MCP@ V@ *.@':J4VC:6[&233;-V8Y9V@7)_'%"DKO0"W&VZ.-B>2H)]ZFJ+&
*!C'0<5+6=RC_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
